British drug found to halve risk of dying from lung cancer
A drug from British pharmaceutical giant has been found to reduce the risk of dying from certain types of lung cancer.
Stay updated with breaking news from Dave Fredrickson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A drug from British pharmaceutical giant has been found to reduce the risk of dying from certain types of lung cancer.
The drug, developed by AstraZeneca, if taken daily after surgery, dramatically reduces risk of death, study shows.
The therapy cut the risk of death by more than half in patients with a certain form of lung cancer who were diagnosed early enough to have their tumour surgically removed, trial data showed.
AstraZeneca's lung cancer therapy, Tagrisso, cut the risk of death by more than half in patients with a certain form of lung cancer who were diagnosed early enough to have their tumour surgically... | June 4, 2023
AstraZeneca has received approval in the United States for the drug combination of ‘Lynparza’, or olaparib, with abiraterone and prednisone or prednisolone for the treatment of adult patients suffering from metastatic castration-resistant prostate cancer (mCRPC) with deleterious or suspected deleterious BRCA mutations, it announced on Thursday.